According to Bayer's latest financial reports the company's current earnings are S$51.05 Billion. In 2022 the company made an earning of S$9.49 Billion, an increase over its 2021 earnings that were of S$5.19 Billion. The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2024 (TTM) | S$2.85 B | |
2022 | S$9.49 B | 82.61% |
2021 | S$5.19 B | -121.58% |
2020 | -S$24.09 Billion | -446.29% |
2019 | S$6.95 B | 9.21% |
2018 | S$6.36 B | -22.12% |
2017 | S$8.17 B | -15.77% |
2016 | S$9.70 B | 3.99% |
2015 | S$9.33 B | -3.59% |
2014 | S$9.68 B | 7.33% |
2013 | S$9.02 B | 15.85% |
2012 | S$7.78 B | 3.19% |
2011 | S$7.54 B | 63.03% |
2010 | S$4.62 B | -17.19% |
2009 | S$5.59 B | -22.85% |
2008 | S$7.24 B | 73.01% |
2007 | S$4.18 B | -0.21% |
2006 | S$4.19 B | -0.7% |
2005 | S$4.22 B | 38.44% |
2004 | S$3.05 B | -229.21% |
2003 | -S$2.37 Billion | |
2001 | S$1.29 B |